164 related articles for article (PubMed ID: 24023645)
1. Increased systemic and local interleukin 9 levels in patients with carotid and coronary atherosclerosis.
Gregersen I; Skjelland M; Holm S; Holven KB; Krogh-Sørensen K; Russell D; Askevold ET; Dahl CP; Ørn S; Gullestad L; Mollnes TE; Ueland T; Aukrust P; Halvorsen B
PLoS One; 2013; 8(8):e72769. PubMed ID: 24023645
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 23 levels are increased in carotid atherosclerosis: possible role for the interleukin 23/interleukin 17 axis.
Abbas A; Gregersen I; Holm S; Daissormont I; Bjerkeli V; Krohg-Sørensen K; Skagen KR; Dahl TB; Russell D; Almås T; Bundgaard D; Alteheld LH; Rashidi A; Dahl CP; Michelsen AE; Biessen EA; Aukrust P; Halvorsen B; Skjelland M
Stroke; 2015 Mar; 46(3):793-9. PubMed ID: 25649806
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation.
Gregersen I; Sandanger Ø; Askevold ET; Sagen EL; Yang K; Holm S; Pedersen TM; Skjelland M; Krohg-Sørensen K; Hansen TV; Dahl TB; Otterdal K; Espevik T; Aukrust P; Yndestad A; Halvorsen B
PLoS One; 2017; 12(11):e0188387. PubMed ID: 29176764
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization.
Dahl TB; Yndestad A; Skjelland M; Øie E; Dahl A; Michelsen A; Damås JK; Tunheim SH; Ueland T; Smith C; Bendz B; Tonstad S; Gullestad L; Frøland SS; Krohg-Sørensen K; Russell D; Aukrust P; Halvorsen B
Circulation; 2007 Feb; 115(8):972-80. PubMed ID: 17283255
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase 7 is associated with symptomatic lesions and adverse events in patients with carotid atherosclerosis.
Abbas A; Aukrust P; Russell D; Krohg-Sørensen K; Almås T; Bundgaard D; Bjerkeli V; Sagen EL; Michelsen AE; Dahl TB; Holm S; Ueland T; Skjelland M; Halvorsen B
PLoS One; 2014; 9(1):e84935. PubMed ID: 24400123
[TBL] [Abstract][Full Text] [Related]
6. Changes and significance of T helper-9 cells and interleukin-9 in patients with atherosclerotic chronic lower limb ischemia: Effect on IL-17 release.
Moaaz M; Lotfy H
Vascular; 2020 Aug; 28(4):378-389. PubMed ID: 32063130
[TBL] [Abstract][Full Text] [Related]
7. [Clinical implication and association between local and systemic levels of interleukin-1β and interleukin-10 in patients with coronary artery disease].
Yan HB; Li WZ; Zhao HJ; Song L; Zheng B; Zhou P; Liu C
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Feb; 39(2):142-6. PubMed ID: 21426749
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis.
Niyonzima N; Bakke SS; Gregersen I; Holm S; Sandanger Ø; Orrem HL; Sporsheim B; Ryan L; Kong XY; Dahl TB; Skjelland M; Sørensen KK; Rokstad AM; Yndestad A; Latz E; Gullestad L; Andersen GØ; Damås JK; Aukrust P; Mollnes TE; Halvorsen B; Espevik T
EBioMedicine; 2020 Oct; 60():102985. PubMed ID: 32927275
[TBL] [Abstract][Full Text] [Related]
9. A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statins.
Breland UM; Halvorsen B; Hol J; Øie E; Paulsson-Berne G; Yndestad A; Smith C; Otterdal K; Hedin U; Waehre T; Sandberg WJ; Frøland SS; Haraldsen G; Gullestad L; Damås JK; Hansson GK; Aukrust P
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):1005-11. PubMed ID: 18276907
[TBL] [Abstract][Full Text] [Related]
10. Circulating CD4+CD25hiCD127lo regulatory T-Cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis.
Ammirati E; Cianflone D; Banfi M; Vecchio V; Palini A; De Metrio M; Marenzi G; Panciroli C; Tumminello G; Anzuini A; Palloshi A; Grigore L; Garlaschelli K; Tramontana S; Tavano D; Airoldi F; Manfredi AA; Catapano AL; Norata GD
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1832-41. PubMed ID: 20539016
[TBL] [Abstract][Full Text] [Related]
11. Stable phase post-MI patients have elevated VEGF levels correlated with inflammation markers, but not with atherosclerotic burden.
ErŽen B; Šilar M; Šabovič M
BMC Cardiovasc Disord; 2014 Nov; 14():166. PubMed ID: 25417001
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets.
Damås JK; Waehre T; Yndestad A; Otterdal K; Hognestad A; Solum NO; Gullestad L; Frøland SS; Aukrust P
Circulation; 2003 Jun; 107(21):2670-6. PubMed ID: 12742982
[TBL] [Abstract][Full Text] [Related]
13. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.
Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X
Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693
[TBL] [Abstract][Full Text] [Related]
14. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability.
Mallat Z; Corbaz A; Scoazec A; Besnard S; Lesèche G; Chvatchko Y; Tedgui A
Circulation; 2001 Oct; 104(14):1598-603. PubMed ID: 11581135
[TBL] [Abstract][Full Text] [Related]
15. Neopterin and atherosclerotic plaque instability in coronary and carotid arteries.
Sugioka K; Naruko T; Matsumura Y; Shirai N; Hozumi T; Yoshiyama M; Ueda M
J Atheroscler Thromb; 2010 Nov; 17(11):1115-21. PubMed ID: 20693747
[TBL] [Abstract][Full Text] [Related]
16. Association of systemic inflammatory activity with coronary and carotid atherosclerosis in the very elderly.
Freitas WM; Quaglia LA; Santos SN; Soares AA; Japiassú AV; Boaventura V; dos Santos Barros E; Córdova C; Nóbrega OT; Sposito AC
Atherosclerosis; 2011 May; 216(1):212-6. PubMed ID: 21316055
[TBL] [Abstract][Full Text] [Related]
17. Decrease in circulating myeloid dendritic cell precursors in coronary artery disease.
Yilmaz A; Weber J; Cicha I; Stumpf C; Klein M; Raithel D; Daniel WG; Garlichs CD
J Am Coll Cardiol; 2006 Jul; 48(1):70-80. PubMed ID: 16814651
[TBL] [Abstract][Full Text] [Related]
18. Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events.
Christersson C; Thulin Å; Siegbahn A
Thromb Haemost; 2017 Jul; 117(8):1571-1581. PubMed ID: 28424820
[TBL] [Abstract][Full Text] [Related]
19. Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease.
Hashmi S; Zeng QT
Coron Artery Dis; 2006 Dec; 17(8):699-706. PubMed ID: 17119379
[TBL] [Abstract][Full Text] [Related]
20. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
Brunner S; Kim JO; Methe H
Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
